Hepatic myeloid-derived suppressor cells in cancer José Medina-EcheverzTobias EggertTim F. Greten Review 02 July 2015 Pages: 931 - 940
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity Masato MutoMuhammad BaghdadiKen-ichiro Seino Original Article 24 April 2015 Pages: 941 - 949
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A Subhashis SarkarMichel van GelderLotte Wieten Original Article Open access 29 April 2015 Pages: 951 - 963
CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion Fei WangLi YangYi Zhang Original Article 06 May 2015 Pages: 965 - 976
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer Joseph P. BalintElizabeth S. GabitzschFrank R. Jones Original Article 09 May 2015 Pages: 977 - 987
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation Marilène BinsfeldMuriel HannonJo Caers Original Article 14 May 2015 Pages: 989 - 998
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study Riccardo DanielliRoberto PatuzzoMario Santinami Original Article 14 May 2015 Pages: 999 - 1009
Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis Snezana Zivancevic-SimonovicOlgica MihaljevicMiodrag Colic Original Article 14 May 2015 Pages: 1011 - 1019
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study Katy J. McCannRosemary GodesethChristian H. Ottensmeier Original Article Open access 16 May 2015 Pages: 1021 - 1032
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice Laura JeanbartIraklis C. KourtisJeffrey A. Hubbell Original Article Open access 16 May 2015 Pages: 1033 - 1046
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial Yoshinari MaedaKiyoshi YoshimuraMasaaki Oka Original Article 16 May 2015 Pages: 1047 - 1056
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice Zili WangEsteban Celis Original Article 19 May 2015 Pages: 1057 - 1066
Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain Alberto AnelLuis Martínez-LostaoJulián Pardo Meeting Report 16 June 2015 Pages: 1067 - 1069